Method For Diagnosis And Prognosis Of Chronic Heart Failure
A technology of heart failure and algorithms, applied in the field of molecular biology, can solve the problems of high morbidity and mortality of heart failure
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0069] Timely diagnosis, accurate classification of heart failure subtypes (including but not limited to heart failure with reduced left ventricular ejection fraction (HFREF), heart failure with preserved left ventricular ejection fraction (HFPEF), etc.) The management and treatment of heart failure are of great importance. An attractive approach is to use circulating biomarkers [14]. An established circulating biomarker in heart failure is cardiac natriuretic peptide, B-type natriuretic peptide (BNP) and its co-secreted congener, the N-terminal hormone probrain natriuretic peptide (NT-proBNP). Both have demonstrated diagnostic utility in acute heart failure and are independently associated with prognosis in all stages of heart failure, making them included in all major international guidelines for the diagnosis and management of heart failure [14,15]. However, confounding factors including age, renal function, obesity, and atrial fibrillation do affect its diagnostic perform...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com